Rayjean J. Hung mainly investigates Cancer, Lung cancer, Internal medicine, Odds ratio and Genome-wide association study. His Cancer research includes elements of Plasma cell, Cancer research, DNA methylation, Gene and Risk factor. His Lung cancer study integrates concerns from other disciplines, such as Respiratory disease, Polymorphism, Immunology, Lung cancer susceptibility and Adenocarcinoma.
His work deals with themes such as Gastroenterology, Endocrinology and Pathology, which intersect with Internal medicine. His Odds ratio research incorporates themes from Case-control study, Oncology, Genotype and Confidence interval. His Genome-wide association study research integrates issues from CHEK2 and Bioinformatics.
Rayjean J. Hung focuses on Lung cancer, Internal medicine, Oncology, Cancer and Genome-wide association study. His Lung cancer research is multidisciplinary, relying on both Genetics, Case-control study, Single-nucleotide polymorphism, Genetic association and Adenocarcinoma. The study incorporates disciplines such as Genotype and Pathology in addition to Internal medicine.
His studies in Oncology integrate themes in fields like Body mass index, Carcinoma, Lung, Hazard ratio and Breast cancer. His study in Cancer is interdisciplinary in nature, drawing from both Epidemiology and Risk factor. Rayjean J. Hung has researched Genome-wide association study in several fields, including Disease, Genetic predisposition, Bioinformatics, Lung cancer susceptibility and Computational biology.
Rayjean J. Hung spends much of his time researching Internal medicine, Oncology, Lung cancer, Genome-wide association study and Cancer. His work on Incidence as part of general Internal medicine research is frequently linked to Mendelian randomization, bridging the gap between disciplines. His studies deal with areas such as MEDLINE, Expression quantitative trait loci, Proportional hazards model, Hazard ratio and Risk factor as well as Oncology.
His Lung cancer research incorporates elements of Odds ratio, Body mass index, Lung, Lung cancer susceptibility and Adenocarcinoma. The Genome-wide association study study combines topics in areas such as Genetic association and Genetic predisposition. His Cancer study combines topics in areas such as Meta-analysis and Relative risk.
His primary scientific interests are in Lung cancer, Internal medicine, Oncology, Genome-wide association study and Adenocarcinoma. The concepts of his Lung cancer study are interwoven with issues in Lung cancer susceptibility, Observational study, Allele and MEDLINE. His work on Hazard ratio, Cancer and Family history as part of general Internal medicine study is frequently linked to Mendelian randomization and Physical activity, bridging the gap between disciplines.
The various areas that Rayjean J. Hung examines in his Cancer study include Relative risk and Antibody. His research integrates issues of Transcriptome, Obesity and Genetic association in his study of Genome-wide association study. His research in Adenocarcinoma intersects with topics in Expression quantitative trait loci, Lung and Locus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung;James D. Mckay;Valerie Gaborieau;Paolo Boffetta.
Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Rayjean J. Hung;Janet Hall;Paul Brennan;Paolo Boffetta.
American Journal of Epidemiology (2005)
Lung cancer susceptibility locus at 5p15.33
James D McKay;Rayjean J Hung;Rayjean J Hung;Valerie Gaborieau;Paolo Boffetta.
Nature Genetics (2008)
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Michael L. Nickerson;Erich Jaeger;Yangu Shi;Jeffrey A. Durocher.
Clinical Cancer Research (2008)
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma.
Maria Teresa Landi;Nilanjan Chatterjee;Kai Yu;Lynn R. Goldin.
American Journal of Human Genetics (2009)
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
Robert Carreras-Torres;Mattias Johansson;Philip C. Haycock;Kaitlin H. Wade.
PLOS ONE (2017)
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer
Yufei Wang;James D McKay;Thorunn Rafnar;Zhaoming Wang.
Nature Genetics (2014)
CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
Rayjean J. Hung;Paolo Boffetta;Jürgen Brockmöller;Dorota Butkiewicz.
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke : distinct patterns in never, former, and current smokers
Florence Le Calvez;Anush Mukeria;Jay D. Hunt;Olaf Kelm.
Cancer Research (2005)
Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis
Darren R. Brenner;Darren R. Brenner;John R. McLaughlin;John R. McLaughlin;John R. McLaughlin;Rayjean J. Hung;Rayjean J. Hung.
PLOS ONE (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: